XML 71 R61.htm IDEA: XBRL DOCUMENT v3.10.0.1
Income Taxes (Details) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 29, 2018
Jun. 30, 2017
Jun. 29, 2018
Jun. 30, 2017
Dec. 29, 2017
Mar. 16, 2018
Feb. 13, 2018
Income Taxes [Line Items]              
Deferred tax benefit, intangible assets       $ (190,600,000)      
Deferred tax expense, Utilization of Tax Attributes       27,200,000      
Income tax benefit $ 53,400,000 $ 53,600,000 $ 96,800,000 95,600,000      
Increase (decrease) tax benefit 200,000   1,200,000        
Increase (Decrease) Tax Expense (Benefit) Due to Pension Settlement     17,500,000        
Increase (Decrease) Deferred Tax Liability Resulting From Tax Reform, TCJA         $ 444,800,000    
Loss (income) from continuing operations before income taxes $ 81,500,000 $ 35,200,000 $ 167,900,000 $ 122,100,000      
Effective tax rate 65.50% 152.30% 57.70% 78.30%      
Current Income Tax Expense (Benefit) $ 9,500,000 $ 33,900,000.0 $ 13,100,000 $ 67,800,000      
Deferred Income Tax Expense (Benefit) (62,900,000) (87,500,000) (109,900,000) (163,400,000)      
Income Taxes Paid, Net     13,700,000   73,400,000    
Income from discontinued operations, net of income taxes 43,700,000 44,400,000 68,700,000 488,500,000      
Unrecognized tax benefits 202,900,000   202,900,000   182,500,000    
Unrecognized tax benefits, net increase     20,400,000        
Unrecognized tax benefits, net increase related to prior period tax positions     19,900,000        
Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities     400,000        
Unrecognized tax benefits, additions related to current year tax positions     900,000        
Unrecognized tax benefits, which if favorably settled would benefit the effective tax rate 190,200,000   190,200,000        
Interest accrued on unrecognized tax benefits 17,800,000   17,800,000   $ 7,100,000    
Unrecognized tax benefits that would impact effective tax rate, upper bound of change 39,800,000   39,800,000        
Income tax penalties and interest accrued that would impact effective tax rate, upper bound of change 6,600,000   6,600,000        
Increase (Decrease) Tax Expense (Benefit) Due to U.S. Tax Reform (9,800,000)   (33,400,000)        
Increase (Decrease) Foreign Tax Expense (Benefit) Due To Acquisitions 3,600,000   8,100,000        
Increase (Decrease) Tax Expense (Benefit) Due to Divestiture     31,200,000        
Increase (Decrease) Tax Expense (Benefit), Change in Operating Income 6,000,000   12,800,000        
Sucampo [Member]              
Income Taxes [Line Items]              
Increase (Decrease) Deferred Tax Asset, Net Operating Losses     (28,000,000)        
Increase (Decrease) Deferred Tax Assets, Tax Credits     2,700,000        
Deferred tax benefit, intangible assets     (180,500,000)        
Increase (Decrease) Deferred Tax Liability, Inventory Step-Up     (24,100,000)        
Increase (Decrease) Deferred Tax Asset, Net     3,100,000        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other             $ 170,800,000
Specialty Generics Disposal Group              
Income Taxes [Line Items]              
Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax (40,300,000) (65,700,000) (69,200,000) (142,000,000)      
Income tax expense 9,000,000 13,500,000 15,800,000 16,000,000      
Income from discontinued operations, net of income taxes 31,300,000 52,200,000 53,400,000 126,000,000      
Nuclear Imaging              
Income Taxes [Line Items]              
Other Tax Expense (Benefit)       1,000,000      
Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax   5,900,000   (371,800,000)      
Contingent Consideration Received, Cash, Discontinued Operation 6,000,000            
Contingent consideration received, equity certificates 9,000,000            
Income tax expense on contingent consideration received, discontinued operations 1,500,000            
Income tax expense   (100,000)   5,300,000      
Income from discontinued operations, net of income taxes   $ (5,800,000)   $ 366,500,000      
Hemostasis Products              
Income Taxes [Line Items]              
Increase (Decrease) in Deferred Tax Liability, Future Consideration     (1,500,000)        
Increase (Decrease) Deferred Tax Asset, Net Operating Losses     (2,400,000)        
Deferred tax benefit, intangible assets     4,200,000        
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount     8,100,000        
Increase (Decrease) Deferred Tax Liability, Inventory Step-Up     3,000,000        
Increase (Decrease), Deferred Tax Liability, Net           $ 3,000,000  
Discontinued Operations [Member]              
Income Taxes [Line Items]              
Unrecognized tax benefits, which if favorably settled would benefit the effective tax rate $ 20,000,000   $ 20,000,000